Elliot M. Offman
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: December 18, 2024
Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication.
Journal: Journal of clinical pharmacology
Published: August 28, 2024
Triple-Antibiotic Combination Exerts Effective Activity against Mycobacterium avium subsp. hominissuis Biofilm and Airway Infection in an In Vivo Murine Model.
Journal: Antibiotics (Basel, Switzerland)
Published: January 14, 2024
Physiologically-based pharmacokinetic modelling to predict intragastric rifabutin concentrations in the treatment of Helicobacter pylori infection.
Journal: Alimentary pharmacology & therapeutics
Published: January 27, 2023
Leveraging in vitro and pharmacokinetic models to support bench to bedside investigation of XTMAB-16 as a novel pulmonary sarcoidosis treatment.
Journal: Frontiers in pharmacology
Published: October 20, 2022
Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With Cancer.
Journal: Clinical pharmacokinetics
Published: August 21, 2020
Brigatinib Dose Rationale in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Exposure-Response Analyses of Pivotal ALTA Study.
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 28, 2020
A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance Exhalation Delivery System Versus Flonase Nasal Spray and Flovent HFA Inhalational Aerosol.
Journal: Clinical therapeutics
Published: April 24, 2019
Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: June 07, 2017
Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers.
Journal: Journal of clinical lipidology
Published: March 10, 2017
No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: February 16, 2017
Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
Journal: European journal of drug metabolism and pharmacokinetics
Published: January 25, 2017
Last Updated: 09/26/2026